Where does Brian O'Callaghan work?

Brian O'Callaghan is Chief Executive Officer at Deep Genomics.

Where did Brian O'Callaghan go to school?

Brian O'Callaghan studied at Henley Business School (Master of Business Administration (M.B.A.), MBA); Marketing Institute Ireland (Diploma); University of Reading (Master of Business Administration (MBA)).

Brian O'Callaghan

Chief Executive Officer at Deep Genomics

United States

Find your path to Brian

397 people in our graph share verified history with Brian — schools, employers, funds. One of them is your warm intro.

Nessan BerminghamunlockedBrian: together at Deep Genomics (2023–2026)

Brian: together at Acucela Inc.

×4Brian: together at Henley Business School

Brian: together at Merck Serono

Chief Executive Officer at Deep Genomics

Intro paths

→

In turn, Brian can intro founders to Deep Genomics's investors below.

Deep Genomics's investors · 7

11.2 CapitalLas Vegas · $500K – $3M checks Bloomberg BetaSan Francisco · $25K – $1M checks Future VenturesLos Altos · $1M – $10M checks Kensington Capital Partners LimitedToronto Magnetic VenturesBoston · $1M – $6M checks SoftBank Vision FundLondon True VenturesSan Francisco · $500K – $3M checks · since 2015

Co-founders at Deep Genomics

Brendan FreyChief Innovation Officer and Founder

Experience

Deep GenomicsChief Executive Officercurrent2023 — presentToronto, Ontario, Canada
Bolt Biotherapeutics, Inc.Chair of the Board of Directorscurrent2021 — presentUnited States
Indaptus Therapeutics, Inc.Member Board Of Directors2021 — 2023New York, United States
ObsEva SAChief Executive Officer2020 — 2023San Diego, CA, United States
BIOCOM PURCHASING GROUP, INC.Member Board of Directors2013 — 2023San Diego County, California, United States
Decoy BiosystemsMember Board of Directors2018 — 2021San Diego County, California, United States
Petra Pharma CorporationChief Executive Officer2017 — 2020New York
Sonrgy, Inc.President & CEO, Chairman Board of Directors2015 — 2017San Diego
Acucela Inc.President & CEO, Member Board of Directors2013 — 2015Seattle
SangartPresident & CEO, Member Board of Directors2008 — 2014San Diego
NPS PharmaChief Commercial Officer2007 — 2008New York City Metropolitan Area
CovanceGlobal Head of CSS & IVRS Divisions2006 — 2007Princeton New Jersey
NovartisGeneral Manager Transplantation & Immunology Division2004 — 2006New York City Metropolitan Area
BioPartnersPresident & CEO, Member Board of Directors2000 — 2004Zurich, Switzerland
Merck SeronoGeneral Manager Biopharmaceuticals Division1996 — 2000Darmstadt, Hesse, Germany
Merck SeronoBusiness Unit Head1994 — 1996London Area, United Kingdom
PfizerSnr Brand Manager1992 — 1994London Area, United Kingdom
BayerMedical Sales Representative1990 — 1992Dublin Ireland

Skills & more

Clinical Development23Clinical Trials14Cross-functional Team Leadership11FDA11Medical Devices9Immunology4Drug Development13Start-ups6Commercialization7Trauma TherapyCardiology3CNS disorders

+8 more

HematologyEndocrinologyVirologyOpthamologyEntrepreneurshipGMPCRO ManagementStrategic Planning

From Brian's professional profile.

Frequently asked questions

Who is Brian O'Callaghan?: Chief Executive Officer at Deep Genomics
Where does Brian O'Callaghan work?: Brian O'Callaghan is Chief Executive Officer at Deep Genomics.
Where did Brian O'Callaghan go to school?: Brian O'Callaghan studied at Henley Business School (Master of Business Administration (M.B.A.), MBA); Marketing Institute Ireland (Diploma); University of Reading (Master of Business Administration (MBA)).

Same school

Also attended Henley Business School95

John HortonInvestor at DN Capital Irene ArdenstedtInvestor at Luminar Ventures Charles VasletSenior Partner, Chief Revenue Officer at Emerald Technology Ventures Ag Sanne van ErpInvestment manager at Noaber Kieran MudryyPartner at 4BIO Capital James ChapmanEntrepreneur in Residence at Cambridge Innovation Capital

+ 89 more

Also attended Marketing Institute Ireland2

John HartnettCEO and Founder at SVG Ventures | THRIVE John HartnettManaging Partner at SVG Ventures

Also attended University of Reading111

Ziad Al-TunisiBoard of Directors (Chairman) at Nuwa Capital Tony CorbinGeneral Partner & Chief Financial Officer at White Star Capital Robert Whitby-SmithInvestor at AlbionVC Julie DaviesFund Accountant at Future Planet Capital Jordan OngInvestment Associate at Future Planet Capital Pierce PolakSenior Associate at Fuel Ventures

+ 105 more

Shared employers

Also worked at Deep Genomics11

Nessan BerminghamInvestor at Khosla Ventures Paul SekhriInvestor at eGenesis, Inc. Full-time Philip FradkinFounder at Blank Bio Dorsa RohaniFounder at Mosaic Brendan FreyChief Innovation Officer and Founder at Deep Genomics David JohnstonChief Financial Officer at Deep Genomics

+ 5 more

Also worked at NPS Pharma8

Sam LeeImpact Partner at Fresco Capital Douglas ReedGeneral Partner at Hatteras Venture Partners David PiersonManaging Director at Syngenta Group Ventures Vanessa WilliamsonVP, Investor Relations at Keiretsu Forum Canada Mark TheeuwesExecutive Officer at Reunion Neuroscience Douglas ReedGeneral Partner at Hatteras

+ 2 more

Also worked at Novartis330

Rebecca JamesInvestor at Index Ventures Scott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at Medicxi Andrea AmadorCompliance Manager at Inveready Technology Investment Group Abbie CelnikerInvestor at Third Rock Ventures Jesper GromadaInvestor at Third Rock Ventures

+ 324 more

Also worked at Pfizer401

Jigar RaythathaInvestor at Third Rock Ventures Abbie CelnikerInvestor at Third Rock Ventures Erin MooreInvestor at Third Rock Ventures Jeb KeiperInvestor at Third Rock Ventures Richard ChesworthInvestor at Third Rock Ventures Michael TaylorOperating Partner at Mission Biocapital

+ 395 more